Company research
ACCENTIA BIOPHARMACEUTICALS INC
CIK 1310094Updated Nov 16, 2026
Securities
Historical securities (1)
ABPI · OTC · equity · closed Jan 15, 2016ABPI price & chart
Historical security
This listing closed Jan 15, 2016. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2012 · USDSource
Source
Source
balance sheet · annual statements
| Line item | FY 2012 | FY 2011 |
|---|---|---|
| ASSETS | ||
| AssetsUSD | 2,584,076Source | 5,914,014Source |
| Property, Plant and Equipment, NetUSD | 965,163Source | 796,238Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 4,406Source | 13,214Source |
| Current assets: | ||
| Cash and Cash Equivalents, at Carrying ValueUSD | 129,168Source | 420,540Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 220,671Source | 1,322,507Source |
| Inventory, NetUSD | 399,963Source | 531,999Source |
| Assets, CurrentUSD | 1,004,384Source | 2,867,297Source |
| Prepaid Expense and Other Assets, CurrentUSD | 183,099Source | 171,230Source |
| Other Assets, NoncurrentUSD | 610,123Source | 692,663Source |
| LIABILITIES AND EQUITY | ||
| LiabilitiesUSD | 82,320,684Source | 92,973,127Source |
| Stockholders’ equity: | ||
| Common Stock, Value, IssuedUSD | 90,209Source | 74,733Source |
| Additional Paid in CapitalUSD | 276,470,206Source | 260,730,525Source |
| Retained Earnings (Accumulated Deficit)USD | -338,192,742Source | -333,870,254Source |
| Stockholders' Equity Attributable to ParentUSD | -63,128,744Source | -74,561,413Source |
| Liabilities and EquityUSD | 2,584,076Source | 5,914,014Source |
| Current liabilities: | ||
| Liabilities, CurrentUSD | 55,964,464Source | 31,268,626Source |
| Accounts Payable, CurrentUSD | 1,176,228Source | 863,294Source |
| Other Liabilities, NoncurrentUSD | 98,069Source | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 16,607,864Source | -12,497,700Source |
| Additional Financial Items | ||
| Accrued Liabilities, CurrentUSD | 1,101,922Source | 499,463Source |
| Long-term DebtUSD | 23,652,000Source | — |
cash flow · annual statements
| Line item | FY 2012 | FY 2011 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -9,187,765Source | -15,653,041Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 3,840,070Source | 16,306,738Source |
| Changes in operating assets and liabilities: | ||
| Increase (Decrease) in Accounts ReceivableUSD | -1,101,836Source | 35,144Source |
| Increase (Decrease) in InventoriesUSD | -132,036Source | 114,912Source |
| Increase (Decrease) in Accounts PayableUSD | 465,854Source | 480,176Source |
| Deferred Income Tax Expense (Benefit)USD | 6,854,879Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -6,309,812Source | -6,115,791Source |
| Cash flows from investing activities: | ||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 5,402,002Source | -789,065Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 97,998Source | 789,065Source |
| Cash flows from financing activities: | ||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 616,438Source | 6,766,944Source |
| Repayments of Long-term DebtUSD | — | 1,718,596Source |
| Supplemental disclosure of cash flow information: | ||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 572,181Source | 209,000Source |
| Additional Financial Items | ||
| AmortizationUSD | 102,555Source | 458,790Source |
| Amortization of Debt Issuance CostsUSD | 99,723Source | 967,338Source |
| DepreciationUSD | 147,285Source | 102,976Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | 1,416,098Source | — |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 1,416,098Source | 1,058,012Source |
| Gain (Loss) on Sale of DerivativesUSD | 1,416,098Source | 1,058,012Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 3,998,105Source | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | 827,196Source |
| General and Administrative ExpenseUSD | 7,414,520Source | 20,245,311Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -9,187,765Source | -15,648,336Source |
| Income Tax Expense (Benefit)USD | — | 4,705Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -4,865,277Source | -4,099,965Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -4,322,488Source | -11,553,076Source |
| Operating ExpensesUSD | 12,822,596Source | 22,637,741Source |
| Payments of Financing CostsUSD | — | 1,059,587Source |
| Proceeds from Issuance of Long-term DebtUSD | — | 7,353,000Source |
| Proceeds from Stock Options ExercisedUSD | 35,509Source | 6,000Source |
income statement · annual statements
| Line item | FY 2012 | FY 2011 |
|---|---|---|
| Total RevenueUSD | 4,054,358Source | 3,955,923Source |
| Cost of Goods and Services Sold | — | — |
| Operating Income (Loss)USD | -11,538,044Source | -21,171,538Source |
| Income Tax Expense (Benefit)USD | — | 4,705Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -4,865,277Source | -4,099,965Source |
| Additional Financial Items | ||
| Cost of Goods Sold (Deprecated 2018-01-31)USD | 1,873,998Source | 1,454,809Source |
| Current Income Tax Expense (Benefit)USD | 609,937Source | — |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 1,416,098Source | 1,058,012Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | 827,196Source |
| General and Administrative ExpenseUSD | 7,414,520Source | 20,245,311Source |
| Gross ProfitUSD | 1,284,552Source | 1,466,203Source |
| Income (Loss) Attributable to Parent, before TaxUSD | — | -11,553,076Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -9,187,765Source | -15,648,336Source |
| Interest ExpenseUSD | 7,908,221Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -4,322,488Source | -11,553,076Source |
| Operating ExpensesUSD | 12,822,596Source | 22,637,741Source |
| Research and Development ExpenseUSD | 5,235,814Source | 2,230,736Source |
| Sales Revenue, Goods, Net (Deprecated 2018-01-31)USD | 3,046,445Source | 2,363,646Source |
| Sales Revenue, Services, Net (Deprecated 2018-01-31)USD | 838,621Source | 1,272,610Source |
| Selling and Marketing ExpenseUSD | 132,262Source | 131,694Source |